Open Call H2020-SMEINST-1-2015: Horizon 2020 Dedicated SME Instrument Phase 1 and 2

European CommissionThe dedicated SME instrument's supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalisation are the prime target.

The SME Instrument offers small and medium-sized businesses the following:

  • Business innovation grants for feasibility assessment purposes (optional phase I): EUR 50,000 (lump sum) per project (70% of total cost of the project);
  • Business innovation grants for innovation development & demonstration purposes (possible phase II): an amount in the indicative range of EUR 500,000 and 2,5 million (70% of total cost of the project as a general rule);
  • Free-of-charge business coaching (optional in phases I and II), in order to support and enhance the firm's innovation capacity and help align the project to strategic business needs;
  • Access to a wide range of innovation support services and facilitated access to risk finance (mostly in optional phase III), to facilitate the commercial exploitation of the innovation.

Topics, further information, documents and submission service:

Deadline Date: 25-11-2015 17:00:00 (Brussels local time)
Cut-off date(s):

  • 18-03-2015 17:00:00 (Brussels local time)
  • 17-06-2015 17:00:00 (Brussels local time)
  • 17-09-2015 17:00:00 (Brussels local time)
  • 25-11-2015 17:00:00 (Brussels local time)

Most Popular Now

Artificial Intelligence in Healthcare Re…

This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of...

First-of-its-Kind Healthcare Communicati…

A web and mobile app-based start-up launched during the COVID-19 pandemic to help UK healthcare professionals communicate with patients has signed its first commercial agreement with a hospital trust...

Giving AI Penalties to Get Better Diagno…

Anyone waiting for the results of a medical test knows the anxious question: 'Will my life change completely when I know?' And the relief if you test negative. Nowadays, Artificial Intelligence...

New App Helps Parents Identify Treatable…

A ground-breaking new, mobile phone app, 'GrowthMonitor' places the accurate measurement of children's height in the hands of parents and carers. Preliminary data to be presented at the Society for...

DMEA Call for Papers: Digital Health in …

26 - 28 April 2022, Berlin, Germany. Health meets digitalisation. From 26 to 28 April 2022 DMEA - Connecting Digital Health, the leading platform for health IT, is opening its doors...

Health Meets IT: DMEA Newcomer Award Inv…

26 - 28 April 2022, Berlin, Germany. Digitalisation of our healthcare sector must be stepped up - the experience of recent months has shown that. It is why new ideas on...

Bittium Exhibits its High-Tech Medical T…

Bittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It...

Development of AI Technology for Produci…

Transcranial focused ultrasound can be used to treat degenerative movement disorders, intractable pain, and mental disorders by delivering ultrasound energy to a specific area of the brain without opening the...

Siemens Healthineers and UCSF Create Fir…

Siemens Healthineers and UC San Francisco have formed a research and innovation-driven collaboration to make radiological imaging greener, while improving access to and quality of radiological imaging in Northern California...

Tulane University Study Uses AI to Detec…

A Tulane University researcher found that artificial intelligence (AI) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study...

Dedalus Acquires Swiftqueue to Support P…

Dedalus Group ("Dedalus"), a leading international healthcare software solutions provider, has announced to have completed the acquisition of 100% of Swiftqueue Technologies Ltd a fast-growing cloud-native appointment and scheduling solution...

FDA Authorizes Marketing of Virtual Real…

The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with...